Risperdal Consta 25 mg

Risperdal Consta 25 mg is a medicine authorised by Swissmedic under authorisation number 56092. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 June 2002 and the authorisation is valid without a time limit. ATC code N05AX08 places the medicine in the group Psycholeptics.

  • Dispensing category B
  • Authorisation number 56092
  • ATC N05AX08
  • Synthetic medicines
Authorisation data
Authorisation number56092
NameRisperdal Consta 25 mg
Full nameRisperdal Consta 25 mg, Suspension zur i.m. Applikation
Authorisation holderJanssen-Cilag AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN05AX08
First authorisation26 June 2002
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Risperdal Consta 25 mg, Suspension zur i.m. ApplikationB26 June 2002
2Risperdal Consta 37,5 mg, Suspension zur i.m. ApplikationB26 June 2002
3Risperdal Consta 50 mg, Suspension zur i.m. ApplikationB26 June 2002

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11SetN05AX0801.05.0.B
31SetN05AX0801.05.0.B
51SetN05AX0801.05.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Risperdal Consta 25 mg authorised in Switzerland?

Yes. Risperdal Consta 25 mg is authorised by Swissmedic under authorisation number 56092, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Risperdal Consta 25 mg have?

Risperdal Consta 25 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Risperdal Consta 25 mg?

The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com